John A. Lust, MD, PhD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
John A. Lust, MD, PhD

John A. Lust, MD, PhD

Healthcare Professional
Consultant
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

John A. Lust is a hematologist/Internist at Mayo Clinic, Rochester, Minnesota. He completed his doctoral degree in Pathology/Immunology from Boston University. He completed his fellowship in hematology/oncology and Residency in Internal Medicine from Mayo Graduate School of Medicine, Mayo Clinic College of Medicine.

Dr. Lust is interested in Molecular biology of hematologic neoplasms and amyloidosis. 

 

Representative Publications:

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine

Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma

Long-term survival (10 years or more) in 30 patients with primary amyloidosis

Phase II trial of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close